Skip to main content

Table 3 Clinical characteristics of participants in the KIND registry (n = 2,912)

From: Establishing the Kidney dIsease in the National guarD (KIND) registry: an opportunity for epidemiological and clinical research in Saudi Arabia

Variable

Male

Female

Total

N (%)

Diabetes Mellitus (ICD10: E10, E11, and E13)

 No

962 (58.4)

703 (55.6)

1,665 (57.2)

 Yes

685 (41.6)

562 (44.4)

1,247 (42.8)

Hypertension (ICD10: I10-I15)

 No

802 (48.7)

598 (47.3)

1,400 (48.1)

 Yes

845 (51.3)

667 (52.7)

1,512 (51.9)

Coronary artery disease (ICD10: I20-I25)

 No

1,591 (96.6)

1,242 (98.2)

2,833 (97.3)

 Yes

56 (3.4)

23 (1.8)

79 (2.7)

Smoking status

 No

266 (16.2)

273 (21.6)

539 (18.5)

 Yes

10 (0.6)

2 (0.2)

12 (0.4)

 Unknown

1,371 (83.2)

990 (78.3)

2,361 (81.1)

Classification of patients (based on kidney disease or KRT)

 Glomerulonephritis

163 (9.9)

131 (10.4)

294 (10.1)

 ESKD on dialysis

449 (27.3)

466 (36.8)

915 (31.4)

 ESKD Post-transplant

441 (26.8)

278 (22.0)

719 (24.7)

 More than one typea

594 (36.1)

390 (30.8)

984 (33.8)

 Mean age (in years) at onset of symptoms (SD)

37.32 (17.6)

37.88 (18.3)

37.55 (17.9)

 Mean age (in years) at biopsy (SD)

38.25 (17.7)

38.23 (18.2)

38.24 (17.9)

Cause of CKD

 Diabetic Nephropathy (ICD-10: E1021, E1022, E1121, E1122, E1322)

559 (33.9)

466 (36.8)

1,025 (35.2)

 Glomerulonephritis (ICD10: N50-N59)

288 (17.5)

214 (16.9)

502 (17.2)

 Hypertensive renal disease (ICD-10: I120, I129-I132)

219 (13.3)

150 (11.9)

369 (12.7)

 Pyelonephritis (ICD10: N10, N12, and N119)

6 (0.4)

6 (0.5)

12 (0.4)

 Polycystic kidney disease (ICD10: Q613)

8 (0.5)

2 (0.2)

10 (0.3)

 Reflux nephropathy (ICD-10: N137)

4 (0.2)

6 (0.5)

10 (0.3)

 Calculi (ICD-10: N20.0 and N200)

7 (0.4)

2 (0.2)

9 (0.3)

 Unknown

407 (24.7)

305 (24.1)

712 (24.5)

 Others (ICD10: N12, N170, I129, Q611, and M1036)

7 (0.4)

9 (0.7)

16 (0.6)

Multiple causes from those listed above

142 (8.6)

105 (8.3)

247 (8.5)

Biopsy details

 No biopsy taken

1,299 (78.9)

1,026 (81.1)

2,325 (79.8)

 Biopsy was taken at NGHA

348 (21.1)

239 (18.9)

587 (20.2)

Family History of Glomerulonephritis

 No

328 (19.9)

231 (18.3)

559 (19.2)

 Yes

7 (0.4)

5 (0.4)

12 (0.4)

 Unknown

1,312 (79.7)

1,029 (81.3)

2,341 (80.4)

Dialysis History

Ever on dialysis

 No

648 (39.3)

435 (34.4)

1,083 (37.2)

 Yes

999 (60.7)

830 (65.6)

1,829 (62.8)

Type of initial dialysis modality (if ever on dialysis)

 Hemodialysis (HD)

924 (92.5)

730 (88.0)

1,654 (90.4)

 Peritoneal dialysis (PD)

61 (6.1)

83 (10.0)

144 (7.9)

 Hemodiafiltration

0 (0.0)

2 (0.2)

2 (0.1)

 Missing

14 (1.4)

15 (1.8)

29 (1.6)

Type of hemodialysis

 High flux

518 (56.1)

490 (67.1)

1,008 (60.9)

 Low flux

3 (0.3)

3 (0.4)

6 (0.4)

 Missing

403 (43.6)

237 (32.5)

640 (38.7)

Type of Peritoneal dialysis

 Continuous ambulatory PD

5 (8.2)

8 (9.6)

13 (9.0)

 Continuous cyclic PD

1 (1.6)

9 (10.8)

10 (6.9)

 Nocturnal intermittent PD

1 (1.6)

2 (2.4)

3 (2.1)

 Missing

54 (88.5)

64 (77.1)

118 (81.9)

  1. CKD Chronic Kidney Disease, ESKD End-stage kidney disease, ICD-10: International classification of diseases-10th revision, KRT Kidney Replacement Therapy, NGHA National Guard Health Affairs, SD standard deviation
  2. aThis category includes participants who had data on more than one type of kidney disease throughout the study period. For example, a Glomerulonephritis patient who received Peritoneal dialysis and then switched to HD